Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
NOVEMBER 17, 2022
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study. Reforming the World Health Organization’s Essential Medicines List: Essential but Unaffordable. Value Health. 2022 Oct 5;379:e071752. N Engl J Med.
184 
Let's personalize your content